Calian Group Ltd. (TSE:CGY – Free Report) – Research analysts at Desjardins decreased their Q3 2025 earnings per share (EPS) estimates for shares of Calian Group in a research report issued on Wednesday, May 14th. Desjardins analyst B. Poirier now forecasts that the company will earn $1.09 per share for the quarter, down from their prior forecast of $1.48. The consensus estimate for Calian Group’s current full-year earnings is $4.95 per share. Desjardins also issued estimates for Calian Group’s Q4 2025 earnings at $1.21 EPS, FY2025 earnings at $4.11 EPS and FY2026 earnings at $4.81 EPS.
Several other analysts also recently issued reports on the company. Royal Bank of Canada lowered their price target on Calian Group from C$65.00 to C$60.00 and set an “outperform” rating for the company in a report on Tuesday, April 22nd. CIBC lowered their price target on Calian Group from C$63.00 to C$62.00 in a report on Friday, February 14th.
Calian Group Trading Down 1.6%
CGY stock opened at C$40.36 on Monday. The company has a market cap of C$479.11 million, a price-to-earnings ratio of 43.22, a PEG ratio of 2.50 and a beta of 0.88. The company has a quick ratio of 1.20, a current ratio of 1.29 and a debt-to-equity ratio of 39.54. The business has a fifty day simple moving average of C$44.78 and a 200-day simple moving average of C$46.51. Calian Group has a 52 week low of C$38.91 and a 52 week high of C$58.60.
Calian Group Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 10th. Investors of record on Tuesday, June 10th will be paid a $0.28 dividend. The ex-dividend date is Tuesday, May 27th. This represents a $1.12 dividend on an annualized basis and a yield of 2.78%. Calian Group’s dividend payout ratio (DPR) is 119.93%.
Calian Group Company Profile
Calian Group Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management.
Featured Articles
- Five stocks we like better than Calian Group
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?
- 5 Top Rated Dividend Stocks to Consider
- What Ray Dalio’s Latest Moves Tell Investors
- What Investors Need to Know to Beat the Market
- Amazon: Why May Is the Last Month to Get the Stock at a Discount
Receive News & Ratings for Calian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calian Group and related companies with MarketBeat.com's FREE daily email newsletter.